150 related articles for article (PubMed ID: 30959137)
1. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
[TBL] [Abstract][Full Text] [Related]
2. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
3. Overview of CD24 as a new molecular marker in ovarian cancer.
Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
[TBL] [Abstract][Full Text] [Related]
4. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
[TBL] [Abstract][Full Text] [Related]
5. RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer.
Zheng C; Yang R
J BUON; 2019; 24(2):715-719. PubMed ID: 31128028
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
7. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
8. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
Runz S; Keller S; Rupp C; Stoeck A; Issa Y; Koensgen D; Mustea A; Sehouli J; Kristiansen G; Altevogt P
Gynecol Oncol; 2007 Dec; 107(3):563-71. PubMed ID: 17900673
[TBL] [Abstract][Full Text] [Related]
9. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.
Keserű JS; Soltész B; Lukács J; Márton É; Szilágyi-Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():76-81. PubMed ID: 31002856
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours.
Nagare RP; Sneha S; Sidhanth C; Roopa S; Murhekar K; Shirley S; Swaminathan R; Sridevi V; Ganesan TS
Cancer Biomark; 2020; 28(3):397-408. PubMed ID: 32224528
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
15. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer.
Gao Y; Zhang C; Liu Y; Wang M
Biosci Trends; 2019 May; 13(2):204-211. PubMed ID: 31019161
[TBL] [Abstract][Full Text] [Related]
17. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
18. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
19. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
20. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
